Elution and Mechanical Properties of Antifungal Bone Cement

Journal of Arthroplasty

Volumn 22, Issue 6, 2007, Pages 902-908

  Goss, Ben ^a   Lutton, Carmen ^a   Weinrauch, Patrick ^a,b   Jabur, Majid ^b   Gillett, Greg ^b   Crawford, Ross ^a,b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

amphotericin B release; bone cement; fungal infection

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; BONE CEMENT; GENTAMICIN; PALACOS; TOBRAMYCIN;

ARTICLE; BIOMECHANICS; COMPRESSIVE STRENGTH; CONTROLLED DRUG RELEASE; ELUTION; MYCOSIS; PROSTHESIS INFECTION; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; ULTRAVIOLET SPECTROSCOPY;

AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BONE CEMENTS; HUMANS; MYCOSES; PROSTHESIS-RELATED INFECTIONS; SPECTRUM ANALYSIS; TOBRAMYCIN;

EID: 34548419172     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2006.09.013     Document Type: Article

References (17)

1. Ridgeway S., Wilson J., Charlet A., et al. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 87 (2005) 844
2. Espehaug B., Engesaeter L.B., Vollset S.E., et al. Review of 10905 primary cemented total hip replacements reported to the Norwegian Arthroplasty Register, 1987 to 1995. J Bone Joint Surg Am 79 (1997) 590
3. Gaston G., and Ogden J. Candida glabrata periprosthetic infection: a case report and literature review. J Arthroplasty 19 (2004) 7
4. Phelan D.M., Osmon D.R., Keating M.R., et al. Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis 34 (2002) 930
5. Selmon G.P.F., Slater R.N.S., Shepperd J.A.N., et al. Successful 1-stage exchange total knee arthroplasty for fungal infection. J Arthroplasty 13 (1998) 1
6. Marra F., Robbins G.M., Masri B.A., et al. Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can J Surg 44 (2001) 5
7. Zimmerli W., Trampuz A., and Ochsner P.E. Prosthetic-joint infections. N Engl J Med 351 (2004) 1645
8. Rex J.H., Walsh T.J., Sobel J.D., et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30 (2000) 662
9. Bernard L., Hoffmeyer P., Assal M., et al. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 53 (2004) 127
10. Bedini A., Venturelli C., Mussini C., et al. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Inf 12 (2006) 1
11. Silverberg D., Kodali P., Dipersio J., et al. In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement. Clin Orthop 403 (2002) 228
12. Gallis H.A., D R.H., and Pickard W.W. B. amphotericin, 30 years of clinical experience. Rev Infect Dis 12 (1990) 308
13. Moran J.M., Greenwald A.S., and Matejczyk M.B. Effect of gentamicin on shear and interface strength of bone cement. Clin Orthop 141 (1979) 96
14. He Y., Trotignon J.P., Loty B., et al. Effect of antibiotics on the properties of poly(methylmethacrylate)-based bone cement. J Biomed Mater Res 63 (2002) 6
15. Lautenschlager E.P., Marshall G.W., Marks K.E., et al. Mechanical strength of acrylic bone cements impregnated with antibiotics. J Biomed Mater Res 10 (1976) 6
16. Nielsen L.E. Crosslinking-effect on physical properties of polymers. J Macromol Sci Rev Macromol Chem 3 (1969) 1
17. Sterling G.J., Crawford S., Potter S.H., et al. The pharmacokinetics of Simplex-Tobramycin bone cement. J Bone Joint Surg Br 85 (2003) 5